Boxer Capital, LLC
- SEC CIK
- 0001465837
- Latest filing
- Feb 14, 2025
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 14, 2024. Long positions only; changes compare share counts with Q3 2023.
- Positions
- 52
- −21 vs. Q3 2023
- Portfolio value
- $2.01B
- +$127.9M (+6.8%) vs. Q3 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MRTXMirati Therapeutics, Inc. | COM | 3,201,440 | $188.1M | 9.4% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 2,100,000 | $175.3M | 8.7% | 00.0% | Unchanged | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,421,541 | $124.9M | 6.2% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 4,279,464 | $122.7M | 6.1% | −404,800−8.6% | Reduced | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,726,000 | $103.3M | 5.1% | 00.0% | Unchanged | History |
| ONCBeOne Medicines Ltd. | ADR | 500,000 | $90.2M | 4.5% | 00.0% | Unchanged | History |
| TYRATyra Biosciences, Inc. | COM | 6,448,359 | $89.3M | 4.5% | 00.0% | Unchanged | History |
| IMGNImmunoGen, Inc. | COM | 2,961,000 | $87.8M | 4.4% | 00.0% | Unchanged | History |
| NUVLNuvalent, Inc. | COM | 1,120,192 | $82.4M | 4.1% | −90,000−7.4% | Reduced | History |
| TNGXTango Therapeutics, Inc. | COM | 8,198,642 | $81.2M | 4.0% | +1,075,000+15.1% | Added | History |
| KRTXKaruna Therapeutics, Inc. | COM | 250,000 | $79.1M | 3.9% | 00.0% | Unchanged | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,202,812 | $78.4M | 3.9% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 650,000 | $62.7M | 3.1% | +50,000+8.3% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 160,000 | $60.9M | 3.0% | +75,000+88.2% | Added | History |
| MRUSMerus N.V. | COM | 1,900,000 | $52.3M | 2.6% | 00.0% | Unchanged | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,466,051 | $43.9M | 2.2% | 00.0% | Unchanged | History |
| IMVTImmunovant, Inc. | COM | 1,000,000 | $42.1M | 2.1% | +250,000+33.3% | Added | History |
| AKROAkero Therapeutics, Inc. | COM | 1,676,733 | $39.2M | 2.0% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 600,000 | $36.1M | 1.8% | 00.0% | Unchanged | History |
| AXSMAxsome Therapeutics, Inc. | COM | 400,000 | $31.8M | 1.6% | 00.0% | Unchanged | History |
| RCUSArcus Biosciences, Inc. | COM | 1,602,200 | $30.6M | 1.5% | 00.0% | Unchanged | History |
| ANABAnaptysbio, Inc | COM | 1,300,000 | $27.8M | 1.4% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 600,000 | $27.6M | 1.4% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 608,614 | $25.1M | 1.2% | +608,614 | New | History |
| PRTAProthena Corp Public Ltd Co | SHS | 665,000 | $24.2M | 1.2% | +40,000+6.4% | Added | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 1,650,000 | $20.2M | 1.0% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 1,819,132 | $20.0M | 1.0% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 1,804,058 | $19.8M | 1.0% | 00.0% | Unchanged | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 1,189,943 | $17.4M | 0.9% | 00.0% | Unchanged | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 400,000 | $16.3M | 0.8% | +400,000 | New | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,732,571 | $15.9M | 0.8% | 00.0% | Unchanged | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,400,000 | $11.4M | 0.6% | −2,305,133−62.2% | Reduced | History |
| PRLDPrelude Therapeutics Inc | COM | 2,568,287 | $11.0M | 0.5% | +73,269+2.9% | Added | History |
| Avidity Biosciences, Inc.05370A108 | COM | 1,121,327 | $10.1M | 0.5% | 00.0% | Unchanged | – |
| NKTXNkarta, Inc. | COM | 1,440,000 | $9.50M | 0.5% | +1,440,000 | New | History |
| ELVNEnliven Therapeutics, Inc. | COM | 646,058 | $8.94M | 0.4% | 00.0% | Unchanged | History |
| THRDThird Harmonic Bio, Inc. | COM | 750,000 | $8.23M | 0.4% | +229,583+44.1% | Added | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 450,000 | $6.82M | 0.3% | 00.0% | Unchanged | History |
| GERNGeron Corp | COM | 3,000,000 | $6.33M | 0.3% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 250,000 | $5.38M | 0.3% | +250,000 | New | History |
| OBIOOrchestra BioMed Holdings, Inc. | COM | 238,193 | $2.17M | 0.1% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 500,000 | $1.87M | 0.1% | 00.0% | Unchanged | History |
| KODKodiak Sciences Inc. | COM | 600,000 | $1.82M | 0.1% | 00.0% | Unchanged | History |
| BCABBioAtla, Inc. | COM | 686,347 | $1.69M | 0.1% | 00.0% | Unchanged | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 506,000 | $1.42M | 0.1% | 00.0% | Unchanged | History |
| Rain Oncology Inc.75082Q105 | COM | 1,152,212 | $1.38M | 0.1% | 00.0% | Unchanged | – |
| MISTMilestone Pharmaceuticals Inc. | COM | 309,007 | $516.0K | <0.1% | 00.0% | Unchanged | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 500,000 | $476.4K | <0.1% | −485,100−49.2% | Reduced | History |
| TARAProtara Therapeutics, Inc. | COM STK | 209,227 | $392.3K | <0.1% | 00.0% | Unchanged | History |
| BCELAtreca, Inc. | CL A COM | 2,202,333 | $290.7K | <0.1% | 00.0% | Unchanged | History |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 266,666 | $16.0K | <0.1% | 00.0% | Unchanged | – |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 66,666 | $1.33K | <0.1% | 00.0% | Unchanged | – |
Sold out since Q3 2023 (25)
Positions held at the end of Q3 2023 that are gone from this filing.
| Security | Class | Shares in Q3 2023 | Value in Q3 2023 | % of portfolio in Q3 2023 | History |
|---|---|---|---|---|---|
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 2,084,000 | $38.2M | 2.0% | History |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 500,000 | $36.5M | 1.9% | – |
| VTYXVentyx Biosciences, Inc. | COM | 850,000 | $29.5M | 1.6% | History |
| FOLDAmicus Therapeutics, Inc. | COM | 2,325,000 | $28.3M | 1.5% | History |
| EXELExelixis, Inc. | COM | 1,150,000 | $25.1M | 1.3% | History |
| SAGESage Therapeutics, Inc. | COM | 1,094,000 | $22.5M | 1.2% | History |
| VKTXViking Therapeutics, Inc. | COM | 2,000,000 | $22.1M | 1.2% | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 3,163,795 | $19.4M | 1.0% | History |
| PNTPOINT Biopharma Global Inc. | COM | 2,500,000 | $16.7M | 0.9% | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 100,000 | $14.6M | 0.8% | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,074,082 | $9.72M | 0.5% | History |
| NRIXNurix Therapeutics, Inc. | COM | 1,224,892 | $9.63M | 0.5% | History |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 2,206,983 | $9.16M | 0.5% | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 95,000 | $8.90M | 0.5% | History |
| GOSSGossamer Bio, Inc. | COM | 6,497,700 | $5.41M | 0.3% | History |
| COGTCogent Biosciences, Inc. | COM | 525,000 | $5.12M | 0.3% | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 770,708 | $4.99M | 0.3% | History |
| RAPTRAPT Therapeutics, Inc. | COM | 300,000 | $4.99M | 0.3% | History |
| MRSNMersana Therapeutics, Inc. | COM | 2,000,000 | $2.54M | 0.1% | History |
| EQRXEQRx, Inc. | COM | 1,000,000 | $2.22M | 0.1% | History |
| TSVT2seventy bio, Inc. | COMMON STOCK | 459,836 | $1.80M | 0.1% | History |
| VRCAVerrica Pharmaceuticals Inc. | COM | 166,955 | $648.6K | <0.1% | History |
| NGMNGM Biopharmaceuticals Inc | COM | 500,000 | $535.0K | <0.1% | History |
| THRXTheseus Pharmaceuticals, Inc. | COM | 150,000 | $403.5K | <0.1% | History |
| TCRTAlaunos Therapeutics, Inc. | COM | 1,100,000 | $145.0K | <0.1% | History |